MRPL42 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 7.142200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.506600E-01
Normal-vs-Stage2
7.628600E-01
Normal-vs-Stage3
6.609800E-01
Normal-vs-Stage4
3.445800E-01
Stage1-vs-Stage2
4.044600E-01
Stage1-vs-Stage3
1.280390E-01
Stage1-vs-Stage4
6.207200E-01
Stage2-vs-Stage3
4.364200E-01
Stage2-vs-Stage4
7.580400E-01
Stage3-vs-Stage4
2.354000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.912600E-01
Normal-vs-AfricanAmerican
7.308800E-01
Normal-vs-Asian
6.708600E-01
Caucasian-vs-AfricanAmerican
9.803800E-01
Caucasian-vs-Asian
1.733640E-01
AfricanAmerican-vs-Asian
3.390000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.809400E-01
Normal-vs-Female
7.470800E-01
Male-vs-Female
4.980800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.110800E-01
Normal-vs-Age(41-60Yrs)
5.451000E-01
Normal-vs-Age(61-80Yrs)
8.235200E-01
Normal-vs-Age(81-100Yrs)
6.561400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.497830E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.206200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.325800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.307700E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.946800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.212400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.520000E-01
Normal-vs-Daily Drinker
9.894800E-01
Normal-vs-Weekly Drinker
9.690400E-01
Normal-vs-Occasional Drinker
4.237200E-01
Normal-vs-Social Drinker
7.192000E-01
Non Drinker-vs-Daily Drinker
8.870000E-01
Non Drinker-vs-Weekly Drinker
8.536200E-01
Non Drinker-vs-Occasional Drinker
6.110400E-02
Non Drinker-vs-Social Drinker
3.689000E-01
Daily Drinker-vs-Weekly Drinker
9.629800E-01
Daily Drinker-vs-Occasional Drinker
8.186000E-02
Daily Drinker-vs-Social Drinker
5.366000E-01
Weekly Drinker-vs-Occasional Drinker
1.472190E-01
Weekly Drinker-vs-Social Drinker
6.096600E-01
Occasional Drinker-vs-Social Drinker
2.784400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.871450E-01
Normal-vs-Grade 2
1.209790E-01
Normal-vs-Grade 3
1.256590E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
9.052600E-01
Grade 1-vs-Grade 3
9.068200E-01
Grade 1-vs-Grade 4
1.871450E-01
Grade 2-vs-Grade 3
9.879800E-01
Grade 2-vs-Grade 4
1.209790E-01
Grade 3-vs-Grade 4
1.256590E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.700200E-01
Normal-vs-NonDiabetic
8.062800E-01
Diabetic-vs-NonDiabetic
7.727400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.642400E-01
Normal-vs-NoPancreatitis
7.593600E-01
Pancreatitis-vs-NoPancreatitis
2.741600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.224400E-01
Normal-vs-N1
7.595400E-01
N0-vs-N1
6.043800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.079000E-01
Normal-vs-TP53-NonMutant
7.155400E-01
TP53-Mutant-vs-TP53-NonMutant
2.690000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
